Progyny Announces $200M Share Repurchase Program, Over 10% of Market Cap
PGNY sits 59% above its 52-week low of $16.1.
Summary
Progyny's board approved a $200 million share repurchase program, to be funded from existing cash balances. This program is substantial, representing over 10% of the company's current market capitalization. It signals management's confidence in the company's valuation and commitment to returning capital to shareholders, potentially providing significant support for the stock price. This follows the company's recent launch of Progyny Select and Q2 revenue guidance.
At the time of this announcement, PGNY was trading at $25.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $16.10 to $28.75. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.